MILTON, N.Y., Sept. 21 /PRNewswire-FirstCall/ -- Sono-Tek Corporation (OTB Bulletin Board: SOTK) the world's leader in ultrasonic spray nozzle technology, announces today that its strategic partner in the field of nanotechnology, NanoBioMagnetics, press released the following item. A copy of the release is attached. NanoBioMagnetics Press Release -- "Strategic Partnership Spawns New Subsidiary Edmond, OK - NanoBioMagnetics, Inc. (NBMI) has announced the formation of a new subsidiary to be called ZetaCor, LLC. The new, wholly-owned subsidiary will produce specialized nanoparticles for research and commercial applications. At the center of ZetaCor's formation is a strategic partnership between NBMI and Sono-Tek of Milton, NY. Early in 2004, NBMI purchased from Sono-Tek one of the first SonoDry ultrasonic spray nozzle systems and is incorporating it into a full lab scale spray drying system. "NBMI provides us with a resource that has extensive expertise in the nanoparticle industry that we have not had to date," says Dr. Chris Coccio, president and CEO of Sono-Tek Corporation. "We believe our partnership with NBMI will shorten Sono-Tek's learning curve for entering products into the nano industry, while providing NBMI unique access to a hardware manufacturer that is willing to customize machinery for their needs." "This partnership represents a marriage of technologies," says Charles Seeney, president and CEO of NBMI. "By combining the technologies developed by Sono-Tek and NBMI, will be able to further refine the nanofabrication of unique powders and composites across a wide range of variables." Seeney points out that the companies, individuals and institutions researching this multifaceted field have very specific requirements for their nanomaterials. NBMI currently produces magnetically responsive nanoparticles for human health applications. NBMI has moved to validation and prototype development of an organ-assisting-device (OAD) technology for hearing amplification. NBMI also is developing OAD technologies for site-specific delivery of therapeutics, currently an area of intense research interest, especially with chemotherapeutics. "Nanotechnology research has come to the point where off-the-shelf nanomaterials are no longer sufficient," says Seeney. "There is a growing market for new, custom nanomaterials created within very narrow parameters for specialized applications. This is our forte. We have the experience and the technology to develop unique nanomaterials capable of meeting exacting standards." For the time being, ZetaCor will share NMBI's Edmond, Oklahoma offices. However, if growth is as rapid as anticipated, ZetaCor will have its own facilities in the near future. " This press release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions and the ability to enforce patents. We refer you to documents that the company files with the Securities and Exchange Commission, which include Form 10-KSB and Form 10-QSB containing additional important information.
SOURCE Sono-Tek Corporation